Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 3/20 | 0.36 |
| ▸ | CNR2 | P34972 | 3/20 | 0.36 |
| ▸ | ESR1 | P03372 | 2/20 | 0.33 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2540709 | 0.87 | KIF11 (0.31) | — | |
| SCHEMBL2542244 | 0.86 | ESR1 (0.36) | ESR1ESR2 | |
| SCHEMBL12120972 | 0.84 | TACR1 (0.32) | — | |
| SCHEMBL2542242 | 0.84 | TACR1 (0.32) | — | |
| SCHEMBL2537214 | 0.83 | CYP1A2 (0.36) | — | |
| SCHEMBL10060954 | 0.83 | ESR1 (0.39) | CNR1CNR2ESR1ESR2ALDH1A1 | |
| SCHEMBL2542680 | 0.82 | TACR1 (0.33) | — | |
| SCHEMBL12120997 | 0.79 | CYP1A2 (0.37) | ALDH1A1CYP3A4 | |
| SCHEMBL2542682 | 0.79 | KIF11 (0.35) | ALDH1A1 | |
| SCHEMBL15435820 | 0.77 | ALDH1A1 (0.33) | ALDH1A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8058478-B2 | Aromatic amine derivative and organic electroluminescence device using the same | IDEMITSU KOSAN CO., LTD. (JP) | 2011-11-15 | — | — | US | disclosed |
| US-8058478-B2 | Aromatic amine derivative and organic electroluminescence device using the same | IDEMITSU KOSAN CO., LTD. (JP) | 2011-11-15 | — | — | US | disclosed |
| US-8044390-B2 | Material for organic electroluminescent device, organic electroluminescent device, and organic electroluminescent display | IDEMITSU KOSAN CO., LTD. (JP) | 2011-10-25 | — | — | US | disclosed |
| US-20110034733-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2011-02-10 | — | — | US | disclosed |
| US-20110034733-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2011-02-10 | — | — | US | disclosed |
| US-7816017-B2 | Aromatic amine derivative and organic electroluminescence device using the same | IDEMITSU KOSAN CO., LTD. (JP) | 2010-10-19 | — | — | US | disclosed |
| US-7816017-B2 | Aromatic amine derivative and organic electroluminescence device using the same | IDEMITSU KOSAN CO., LTD. (JP) | 2010-10-19 | — | — | US | disclosed |
| US-20100181555-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENT DEVICE, ORGANIC ELECTROLUMINESCENT DEVICE, AND ORGANIC ELECTROLUMINESCENT DISPLAY | IDEMITSU KOSAN CO., LTD. (JP) | 2010-07-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110034733-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | TYR, DDC, EML4 | CNR1 4442/4885CNR2 4026/4885ESR1 126/4885 |
| US-20100181555-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENT DEVICE, ORGANIC ELECTROLUMINESCENT DEVICE, AND ORGANIC ELECTROLUMINESCENT DISPLAY | AFF4, CLIC4, L1CAM | CNR1 1715/4885CNR2 1871/4885ESR1 108/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.